Lupin launches generic hypertentsion drug in US
The company has launched its Amlodipine and Valsartan tablets in the US market.
New Delhi, April 1, 2015: Lupin has launched its Amlodipine and Valsartan tablets, used for the treatment of hypertension, in the US market. The company said in a statement that its US arm, Lupin Pharmaceuticals Inc has launched Amlodipine and Valsartan in various strengths in the US market after securing final approval from the US Food and Drugs Administration (USFDA). The tablets launched by Lupin are the generic version of Novartis Pharmaceuticals Corporation's Exforge tablets.
As per IMS MAT sales data, Exforge tablets had US sales of US$ 414.9 million. With this approval, the Mumbai-based drug firm has received six abbreviated new drug approvals (ANDAs) in the last three months.